Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024
Provided By GlobeNewswire
Last update: Aug 14, 2024
- Preliminary data from the Phase 1 trial of PYX-201 remains on track to be announced in the fall of 2024
- Preliminary data from the Phase 1 trial of PYX-106 is expected to be reported by year-end 2024
Read more at globenewswire.com
